RG
Regen BioPharma, Inc.
RGBP · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $3.16K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0001
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RGBP is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.02x
PEG N/A
P/E N/A
Growth
21 /100
Declining Rev. growth 0.15%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 384.37%
Gross margin 84.87%
FCF margin 212.90%
Quality
61 /100
Average Asset turnover 0.73x
ROIC 16.23%
ROA 412.46%
Debt
0 /100
High Int. coverage -8.33x
Current ratio 0.05x
Debt/Assets N/A
Stability
33 /100
Unstable EPS volatility 140.41%
Beta 0.23x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RGBP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Raymond Koos
Employees
1
Headquarters
La Mesa